Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intermediate Expanded Use Trial of DFMO

NCT03581240 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03581240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intermediate Expanded Use Trial of DFMO
Lead sponsor
Giselle Sholler
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

embryonal tumor with abundant neuropil and true rosettes, ependymoblastoma, medulloblastoma, medulloepithelioma, neuroblastoma, typical teratoid rhabdoid tumor